These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 37395401

  • 1. Aspartame use and Parkinson's disease: review of associated effects on neurotransmitters, oxidative stress, and cognition.
    Kushigian DJ, Vaou OE.
    Nutr Neurosci; 2024 May; 27(5):506-519. PubMed ID: 37395401
    [Abstract] [Full Text] [Related]

  • 2. Cognitive and biochemical effects of monosodium glutamate and aspartame, administered individually and in combination in male albino mice.
    Abu-Taweel GM, A ZM, Ajarem JS, Ahmad M.
    Neurotoxicol Teratol; 2014 May; 42():60-7. PubMed ID: 24556450
    [Abstract] [Full Text] [Related]

  • 3. Zebrafish Behavioral Phenomics Links Artificial Sweetener Aspartame to Behavioral Toxicity and Neurotransmitter Homeostasis.
    Li X, Dong G, Han G, Du L, Li M.
    J Agric Food Chem; 2021 Dec 22; 69(50):15393-15402. PubMed ID: 34874711
    [Abstract] [Full Text] [Related]

  • 4. Neurophysiological symptoms and aspartame: What is the connection?
    Choudhary AK, Lee YY.
    Nutr Neurosci; 2018 Jun 22; 21(5):306-316. PubMed ID: 28198207
    [Abstract] [Full Text] [Related]

  • 5. Studies on the effects of aspartame on memory and oxidative stress in brain of mice.
    Abdel-Salam OM, Salem NA, El-Shamarka ME, Hussein JS, Ahmed NA, El-Nagar ME.
    Eur Rev Med Pharmacol Sci; 2012 Dec 22; 16(15):2092-101. PubMed ID: 23280025
    [Abstract] [Full Text] [Related]

  • 6. The in vitro cytotoxic, genotoxic, and oxidative damage potentials of the oral artificial sweetener aspartame on cultured human blood cells.
    Çadirci K, Özdemir Tozlu Ö, Türkez H, Mardinoğlu A.
    Turk J Med Sci; 2020 Apr 09; 50(2):448-454. PubMed ID: 32222132
    [Abstract] [Full Text] [Related]

  • 7. Effect of aspartame on oxidative stress and monoamine neurotransmitter levels in lipopolysaccharide-treated mice.
    Abdel-Salam OM, Salem NA, Hussein JS.
    Neurotox Res; 2012 Apr 09; 21(3):245-55. PubMed ID: 21822758
    [Abstract] [Full Text] [Related]

  • 8. Aspartame and Risk of Cancer: A Meta-analytic Review.
    Mallikarjun S, Sieburth RM.
    Arch Environ Occup Health; 2015 Apr 09; 70(3):133-41. PubMed ID: 24965331
    [Abstract] [Full Text] [Related]

  • 9. Dietary aspartame with protein on plasma and brain amino acids, brain monoamines and behavior in rats.
    Torii K, Mimura T, Takasaki Y, Ichimura M.
    Physiol Behav; 1986 Apr 09; 36(4):765-71. PubMed ID: 3714850
    [Abstract] [Full Text] [Related]

  • 10. Daytime aspartame intake results in larger influences on body weight, serum corticosterone level, serum/cerebral cytokines levels and depressive-like behaviors in mice than nighttime intake.
    Ma H, Deng J, Liu J, Jin X, Yang J.
    Neurotoxicology; 2024 May 09; 102():37-47. PubMed ID: 38499183
    [Abstract] [Full Text] [Related]

  • 11. The carcinogenic effects of aspartame: The urgent need for regulatory re-evaluation.
    Soffritti M, Padovani M, Tibaldi E, Falcioni L, Manservisi F, Belpoggi F.
    Am J Ind Med; 2014 Apr 09; 57(4):383-97. PubMed ID: 24436139
    [Abstract] [Full Text] [Related]

  • 12. l-Theanine ameliorates motor deficit, mitochondrial dysfunction, and neurodegeneration against chronic tramadol induced rats model of Parkinson's disease.
    Raj K, Gupta GD, Singh S.
    Drug Chem Toxicol; 2022 Sep 09; 45(5):2097-2108. PubMed ID: 34210222
    [Abstract] [Full Text] [Related]

  • 13. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease.
    Khurana N, Gajbhiye A.
    Neurotoxicology; 2013 Dec 09; 39():57-64. PubMed ID: 23994302
    [Abstract] [Full Text] [Related]

  • 14. Effect of mealing on plasma and brain amino acid, and brain monoamine in rats after oral aspartame.
    Torii K, Mimura T, Takasaki Y, Ichimura M.
    Physiol Behav; 1986 Dec 09; 36(4):759-64. PubMed ID: 2940610
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of aspartame on large neutral amino acids and monoamines in rat brain.
    Fernstrom JD, Fernstrom MH, Gillis MA.
    Life Sci; 1983 Apr 04; 32(14):1651-8. PubMed ID: 6835009
    [Abstract] [Full Text] [Related]

  • 16. Aspartame exposure and in vitro hippocampal slice excitability and plasticity.
    Fountain SB, Hennes SK, Teyler TJ.
    Fundam Appl Toxicol; 1988 Aug 04; 11(2):221-8. PubMed ID: 3220201
    [Abstract] [Full Text] [Related]

  • 17. Consuming aspartame with and without taste: differential effects on appetite and food intake of young adult males.
    Black RM, Leiter LA, Anderson GH.
    Physiol Behav; 1993 Mar 04; 53(3):459-66. PubMed ID: 8451310
    [Abstract] [Full Text] [Related]

  • 18. Cognition and serotonin in Parkinson's disease.
    Frouni I, Kwan C, Belliveau S, Huot P.
    Prog Brain Res; 2022 Mar 04; 269(1):373-403. PubMed ID: 35248202
    [Abstract] [Full Text] [Related]

  • 19. The debate over neurotransmitter interaction in aspartame usage.
    Choudhary AK, Lee YY.
    J Clin Neurosci; 2018 Oct 04; 56():7-15. PubMed ID: 30318075
    [Abstract] [Full Text] [Related]

  • 20. Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics.
    Yadav D, Kumar P.
    Neurochem Int; 2022 Jun 04; 156():105327. PubMed ID: 35331828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.